Header

Header

Header

Degenerate Bases & Mixed-Nucleotide Oligonucleotides

Custom degenerate DNA and RNA oligonucleotides using IUPAC mixed-base codes, biased ratios, randomers, UMIs, barcodes, NNK/NNS codons, and trimer codon mixes.

IUPAC Mixed Bases NNK / NNS Libraries Biased Ratios Randomers & UMIs Optional NGS Validation

Controlled Sequence Diversity Through Mixed-Base Synthesis

Degenerate base oligonucleotides incorporate defined mixtures of nucleotides at selected positions during synthesis to generate controlled sequence diversity within a single oligonucleotide pool.

These mixed-base strategies are used for UMIs and barcodes, randomers, NNK/NNS codon mutagenesis, biased nucleotide libraries, inclusive primers, aptamer pools, and combinatorial screening workflows.

Bio-Synthesis offers oligonucleotides containing randomized or mixed bases. The final order contains a population of oligos in which different molecules carry different bases at the randomized position. Mixed-base oligos are useful for creating pools that include matches to a variable or unknown template sequence, as well as for generating diversity in clone libraries, site-directed mutagenesis, barcoding, UMIs and combinatorial screening workflows.

Two randomization approaches are available: standard mixed bases and custom mixed bases. Standard mixed bases use equal dispensing ratios at the selected position, such as A:C:G:T at 25:25:25:25, A:C:G at approximately 33:33:33:00, or A:C at 50:50:00:00. Standard mixed bases can be inserted at one or more positions in a sequence and are the most economical option for routine degenerate oligos.

Custom mixed bases are used when defined or unequal ratios are required, such as enriching or reducing specific bases at selected positions. Custom formulations are useful for biased libraries, motif scanning, codon tuning and representation control. Actual pool composition can vary because phosphoramidites have different coupling efficiencies, so critical libraries may benefit from composition reporting or optional sentinel-site or full-length NGS validation.

Bio-Synthesis manufactures custom degenerate DNA and RNA oligonucleotides with IUPAC mixed-base code design, per-site A/C/G/T dosing, biased ratios, trimer codon strategies, inosine or universal base placement, purification planning, composition reporting, optional validation, and RUO-to-GMP-like documentation.

R Y S W K M B D H V NCustom % DopingNNK / NNSInosine & Universal BaseDesalt / HPLC / UPLC

EXAMPLE LIBRARY DESIGN

A T G N N K N N K T G G
32

codons per NNK site

1

stop codon per NNK set

1024

two-site NNK combinations

EXPANDED DEGENERATE POSITIONS

N
A C G T
K
G T
S
G C
Custom %
10 40 40 10

IUPAC Degenerate Codes

Keep this table as a practical reference for designing mixed-base oligonucleotides, inclusive primers, randomers, barcodes and codon libraries.

Degenerate Base Codes, Base Sets & Default Mixes

Default equimolar ratios can be adjusted when biased representation is required.

IUPAC degenerate nucleotide codes for mixed-base oligonucleotide synthesis.

Code Meaning Base Set Default Mix Notes
R Purine A or G 50:50 Biased ratios available on request
Y Pyrimidine C or T 50:50 Use U instead of T in RNA designs
S Strong G or C 50:50 Common in NNS codon schemes
W Weak A or T 50:50 Useful for AT-rich alternatives
K Keto G or T 50:50 Common in NNK codon schemes
M Amino A or C 50:50 Useful for targeted motif variation
B Not A C/G/T ≈33:33:33 Can bias away from G if needed
D Not C A/G/T ≈33:33:33 Custom ratios available
H Not G A/C/T ≈33:33:33 Useful where G-rich artifacts are a concern
V Not T(U) A/C/G ≈33:33:33 Use not-U logic for RNA
N Any base A/C/G/T ≈25:25:25:25 Custom examples include A:10/C:40/G:40/T:10

Codon design note: NNK uses N,N,K = G/T and creates 32 codons with one stop codon. NNS uses N,N,S = G/C and provides a similar reduced-stop strategy. Trimer codon mixes offer stricter amino-acid control.

Products We Support: Degenerate & Mixed-Nucleotide Oligos

Compare supported degenerate oligo formats by design type, function, application and ordering code.

Representative Degenerate Oligonucleotide Formats

Choose the format based on whether the goal is sequence diversity, codon randomization, biased distribution, pairing tolerance or combinatorial scanning.

Representative degenerate base and mixed-nucleotide oligonucleotide products supported by Bio-Synthesis.

Product / Modification Description Function Application Code
Equimolar Degenerate Mix Standard IUPAC mixes at specified positions, including R, Y, S, W, K, M, B, D, H, V and N. Controlled variability UMIs, barcodes and inclusive primers [IUPAC-Std]
Biased Degenerate Mix Non-equimolar ratios per position, such as A:10/C:40/G:40/T:10. Tuned distributions Directed evolution, motif tiling and representation control [IUPAC-Bias]
NNK / NNS Codon Mix Per-codon dosing to reduce stop codons relative to NNN. Codon randomization Protein libraries and saturation mutagenesis [NNK] [NNS]
Trimer Codon Mix Defined codon trimers for more uniform amino-acid coverage. Reduce codon bias High-quality protein engineering libraries [TriCodon]
Inosine at Variable Sites dI or rI wobble base for tolerance across multiple pairing possibilities. Pairing tolerance Inclusive primers and probes [Ino]
Universal Base Universal base analog such as 5-nitroindole; may reduce Tm. Position flexibility Uncertain positions and scanning studies [UB]
Combinatorial Pools Degenerate windows tiled across regions with per-site mix control. Coverage scanning Promoter, motif and aptamer discovery [Pool-Tile]

Availability note: Final representation, diversity and validation options should be confirmed during quote review. Customizations: per-site ratios, barred bases such as “not G,” length and scale options, desalt versus HPLC/UPLC, aliquots, kitting, barcoding, CoA, method summaries and RUO-to-GMP-like documentation are available on request.

Design, Dosing & Validation Considerations

Degenerate oligo performance depends on the designed diversity, synthesis dosing, purification approach and downstream sampling depth.

DOSE

Per-Cycle Dosing

A/C/G/T are metered according to the requested IUPAC code or custom percentage ratio. Ratios can vary by position within the same sequence.

BIAS

Bias Management

Base reactivity differences can be compensated during dosing. Composition can be monitored by synthesis data and optional sequencing validation.

POOL

Pools & Purification

Desalt typically maximizes library diversity. HPLC/UPLC improves purity but may reduce representation, so purification should match the assay.

NGS

Composition Validation

Sentinel-site or full-length NGS can quantify base distributions and confirm dosing accuracy for critical libraries.

Complexity & Sampling

Plan sampling depth around the unique space. A practical rule is to sample at least 10× the designed complexity where representation matters, especially for randomers and UMI pools.

Tm & Hybridization

Degenerate positions broaden thermal behavior. Inosine and universal bases can improve tolerance but may lower Tm, so length and ionic strength may need adjustment.

Applications for Degenerate Base Oligonucleotides

Degenerate oligos are used when controlled sequence diversity or pairing tolerance is needed within a defined synthetic oligonucleotide pool.

UMI

UMIs & Barcodes

Randomers and structured barcode pools for molecule tracking, deduplication, error correction and sequencing workflows.

Explore Application →

NNK

Protein Mutagenesis Libraries

NNK/NNS codon randomization and trimer codon mixes for saturation mutagenesis and protein engineering.

Explore Application →

PCR

Inclusive PCR Primers

Degenerate positions, inosine and universal bases improve coverage where target sequences vary.

Explore Application →

PRO

Probe & Assay Robustness

Mixed positions can improve inclusivity and performance across sequence variants.

Explore Application →

APT

Aptamer Discovery Pools

Randomized and biased libraries for selection, enrichment and binding motif discovery.

Explore Application →

SCAN

Motif Tiling & Scanning

Windowed combinatorial pools for promoter mapping, regulatory motif exploration and structure-function screening.

Application Use Case

FAQ

What are IUPAC degenerate bases?
IUPAC degenerate base codes define mixtures of nucleotides at a specific synthesis position. For example, R means A/G, Y means C/T, and N means A/C/G/T.
What’s the difference between NNK and NNS schemes?
NNK uses K = G/T, while NNS uses S = G/C. Both reduce stop codons compared with NNN and are common for codon mutagenesis libraries. Trimer codon mixes provide even stricter amino-acid control.
Can Bio-Synthesis make biased non-equimolar mixes?
Yes. Bio-Synthesis can dose custom percentages per position, such as A:10/C:40/G:40/T:10, and provide composition reporting or optional NGS validation when needed.
Will HPLC purification reduce diversity in randomers?
It can. Desalting maximizes representation, while HPLC or UPLC improves purity but may reduce representation. The best purification method depends on the downstream assay.
Do you offer NGS composition validation?
Yes. Sentinel-site or full-length NGS can quantify base distributions and confirm dosing accuracy for critical libraries or high-complexity pools.
What’s the role of inosine and universal bases?
Inosine provides wobble pairing tolerance. Universal bases such as 5-nitroindole can help at uncertain positions but may lower melting temperature, so sequence length may need adjustment.
What is the difference between standard and custom mixed bases?
 Standard mixed bases use equal dispensing ratios for the selected bases, such as 25:25:25:25 for N or 50:50 for a two-base mix. Custom mixed bases use user-defined ratios, including unequal formulations, and are recommended when representation control is important.
Should I choose NNK, NNS or trimer codons?
 NNK and NNS are practical lower-cost options for codon randomization because they reduce stop codons compared with NNN. Trimer codon mixes are preferred when more even amino-acid representation or exclusion of specific amino acids is required.

Information Helpful for Degenerate Oligo Design

Sequence
DNA/RNA sequence and variable positions
Codes or Ratios
IUPAC codes, NNK/NNS or custom %
Complexity
Target diversity and sampling plan
Purification
Desalt, HPLC or UPLC preference
Validation
Composition report, NGS or CoA needs

Ready to specify your degenerate design?

Share your sequence, degenerate positions, IUPAC codes or percentage ratios, desired complexity, NNK/NNS or trimer scheme, purification target and validation requirements. Bio-Synthesis can help align the mixture design, synthesis dosing, purification and QC plan with your downstream application.
N

Related Services

Related oligo synthesis and library design services.

Fast Quote Checklist

Include sequence, codes, ratios, complexity, purification and validation.

Sequence Codes Ratios Purity NGS

Scientific Background & Recommended Reading

Selected references covering IUPAC ambiguity codes, UMI/barcode design, codon randomization and trimer codon library construction. These references provide scientific background and design context.

  1. IUPAC-IUB Commission on Biochemical Nomenclature. Abbreviations and symbols for nucleic acids, polynucleotides and their constituents. Foundational nomenclature for mixed-base and ambiguity codes.
  2. Kinde I, Wu J, Papadopoulos N, Kinzler KW, Vogelstein B. Detection and quantification of rare mutations with massively parallel sequencing. PNAS. 2011;108(23):9530-9535. DOI
  3. Schmitt MW, et al. Detection of ultra-rare mutations by next-generation sequencing. PNAS. 2012;109(36):14508-14513. DOI
  4. Hughes RA, Ellington AD. Synthetic DNA synthesis and assembly: putting the synthetic in synthetic biology. Cold Spring Harbor Perspectives in Biology. 2017;9(1):a023812. DOI

Note: Reference selection should be aligned with the final library design, synthesis scale, sampling strategy and validation method. Bio-Synthesis can help translate mixture specifications into manufacturable oligo designs.

Why Choose Bio-Synthesis

Trusted by biotech leaders worldwide for over 45+ years of delivering high quality, fast and scalable synthetic biology solutions.